RMTG (Regenerative Medical Technology Group) Net Margin %: -33.19% (As of Mar. 2026)

What is Regenerative Medical Technology Group Net Margin %?

Regenerative Medical Technology Group RMTG +0.44% Net Margin % is -33.19% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, Regenerative Medical Technology Group ranks worse than 53.43% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Regenerative Medical Technology Group's Net Income for the three months ended in Mar. 2026 was $-0.88 Mil. Regenerative Medical Technology Group's Revenue for the three months ended in Mar. 2026 was $2.64 Mil. Therefore, Regenerative Medical Technology Group's net margin for the quarter that ended in Mar. 2026 was -33.19%.

The historical rank and industry rank for Regenerative Medical Technology Group's Net Margin % or its related term are showing as below:

RMTG' s Net Margin % Range Over the Past 10 Years
Min: -10720 Med: -1300 Max: -124.36
Current: -124.36

RMTG's Net Margin % is ranked worse than
53.43% of 947 companies
in the Biotechnology industry
Industry Median: -89.33 vs RMTG: -124.36

Regenerative Medical Technology Group (OTCPK:RMTG) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Regenerative Medical Technology Group Net Margin % Related Terms

Regenerative Medical Technology Group Net Margin % Historical Data

* Premium members only.

The historical data trend for Regenerative Medical Technology Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerative Medical Technology Group Net Margin % Chart

Regenerative Medical Technology Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Net Margin %

Get a 7-Day Free Trial

-2,941.55

-359.93

-407.22

-135.45

-153.18

Regenerative Medical Technology Group Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Net Margin %	Get a 7-Day Free Trial															-55.72	-132.72	-368.67	-88.61	-33.19

RMTG vs WINT, LIPO, CYTOF: Net Margin % Comparison

For the Biotechnology subindustry, Regenerative Medical Technology Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's Net Margin % falls into.

Save Embed

Regenerative Medical Technology Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Regenerative Medical Technology Group's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin	=	Net Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-7.812	/	5.1
	=	-153.18 %

Regenerative Medical Technology Group's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin	=	Net Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.876	/	2.639
	=	-33.19 %

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of -33.19% mean?

Regenerative Medical Technology Group (RMTG) has a Net Margin % of -33.19% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Regenerative Medical Technology Group and its competitors. According to the industry distribution chart, Regenerative Medical Technology Group ranks #506 out of 947 companies in the Biotechnology industry, placing it in the top 53.4%.

Is Regenerative Medical Technology Group's Net Margin % too high?

Regenerative Medical Technology Group's current Net Margin % is -33.19%. Based on the distribution chart, Regenerative Medical Technology Group ranks #506 out of 947 companies in the Biotechnology industry, which is below the industry midpoint.

How does Regenerative Medical Technology Group's Net Margin % compare to WINT and LIPO?

According to the Biotechnology industry distribution chart, Regenerative Medical Technology Group ranks #506 out of 947 companies for Net Margin %. This places Regenerative Medical Technology Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Biotechnology company?

A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Regenerative Medical Technology Group and its competitors. Regenerative Medical Technology Group's current Net Margin % is -33.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Regenerative Medical Technology Group stock overvalued right now?

Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.06, compared to a current price of $0.05 — trading 24.7% below its estimated fair value. The current Net Margin % is -33.19%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current Net Margin % is -33.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Industry Healthcare Biotechnology

Comparable Companies WINT LIPO CYTOF EMMA CNBX IOBTQ ENDV CERO RGBP AGTX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432

Website https://www.regenmedtechgroup.com

Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.